Aspirin Underused in Secondary Prevention of Cardiovascular Disease
Estimates of use increased from 16.6 percent in low-income countries to 65.0 percent in high-income countries
Prognostic Factors ID’d for Stage IIIb AL Amyloidosis
Symptom onset to diagnosis longer than six months, bone marrow plasmacytosis ≥10 percent associated with shorter overall survival
Canagliflozin Reduces Cardiorenal Biomarkers in T2D
Increase in biomarkers and multimarker panel linked to increased risk for primary cardiorenal outcome
Heterogeneity Found in Appropriate Use Criteria for Imaging of CAD
CMS-qualified AUC for coronary artery disease heterogeneous, sometimes conflict with respect to appropriateness
Arterial Stiffness Progression Precedes Cardiac Damage in Teens
Increased systolic blood pressure and insulin resistance partially mediated relationship
Semaglutide Can Cut Prevalence of Obesity, CVD in Eligible U.S. Adults
Applying STEP 1 treatment would result in a 46.1 percent reduction in obesity prevalence and 17.8 percent relative risk reduction in CVD
Incidence of New-Onset HTN Higher for COVID-19 Versus Influenza Patients
Hospitalized and nonhospitalized patients with COVID-19 more likely to develop persistent HTN than those with influenza
Prolonged Direct Oral Anticoagulants Beneficial for Preventing Recurrent VTE
Findings seen among adults prescribed warfarin, DOACs beyond six months after acute venous thromboembolism
Breastfeeding for at Least Six Months Aids Maternal Cardiovascular Factors
Findings similar for women who experienced a complication of pregnancy
Six, 12 Weeks of Cytisinicline Efficacious for Smoking Cessation
Cytisinicline well tolerated with only 2.9 percent of participants discontinuing due to an adverse event
